SCHEMBL20733585

SCHEMBL20733585

C[C@@]1(O)[C@@H](COC(=O)c2ccccc2)OC(O)[C@@H]1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
CHRNB2 P17787 1/20 0.45
CHRNA5 P30532 1/20 0.45
CHRNA7 P36544 1/20 0.45
CHRNA4 P43681 1/20 0.45
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
NPC1 O15118 1/20 0.41
CES2 O00748 1/20 0.41
TSHR P16473 1/20 0.41
CARM1 Q86X55 1/20 0.41
PRMT6 Q96LA8 1/20 0.41
MAPK1 P28482 2/20 0.41
HIF1A Q16665 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KMT2A Q03164 1/20 0.41
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16576322 1.00 ALDH1A1 (0.52) ALDH1A1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL17976785 1.00 ALDH1A1 (0.52) ALDH1A1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL20557343 1.00 ALDH1A1 (0.52) ALDH1A1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL15414469 0.85 ALDH1A1 (0.49) ALDH1A1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL14615421 0.85 ALDH1A1 (0.49) ALDH1A1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL13649180 0.84 ALDH1A1 (0.51) ALDH1A1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL13708365 0.84 ALDH1A1 (0.53) ALDH1A1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL27195217 0.83 ALDH1A1 (0.44) ALDH1A1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL27195193 0.83 ALDH1A1 (0.44) ALDH1A1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL28718478 0.82 ALDH1A1 (0.47) ALDH1A1CHRNB2CHRNA5CHRNA7CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240368204-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2024-11-07 US disclosed
EP-4353732-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-04-17 EP disclosed
CN-117642411-A Small molecule CD73 antagonists and uses thereof 西藏海思科制药有限公司 2024-03-01 CN disclosed
WO-2022237747-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF 四川海思科制药有限公司 2022-11-17 WO disclosed
WO-2022237747-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF 四川海思科制药有限公司 2022-11-17 WO disclosed
US-20220160713-A1 SELECTIVE INHIBITOR OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) WILMINGTON PHARMATECH COMPANY, LLC 2022-05-26 US disclosed
US-11208416-B2 Selective inhibitors of protein arginine methytransterase 5 (PRMT5) PRELUDE THERAPEUTICS INCORPORATED (US) 2021-12-28 US disclosed
US-11078205-B2 Selective inhibitors of protein arginine methlytransferase 5 (PRMT5) PRELUDE THERAPEUTICS, INCORPORATED (US) 2021-08-03 US disclosed
US-20200361946-A1 Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5) PRELUDE THERAPEUTICS INC (US) 2020-11-19 US disclosed
US-20200148692-A1 Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5) PRELUDE THERAPEUTICS INC (US) 2020-05-14 US disclosed
WO-2019032859-A1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) PRELUDE THERAPEUTICS, INCORPORATED (US) 2019-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078205-B2 Selective inhibitors of protein arginine methlytransferase 5 (PRMT5) PRMT5, PRMT1, PRMT3 ALDH1A1 3226/4885CHRNB2 4165/4885CHRNA5 2029/4885
US-20240368204-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF ENTPD5, ENTPD1, ENTPD2 ALDH1A1 507/4885CHRNB2 777/4885CHRNA5 236/4885
US-20200148692-A1 Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5) PRMT5, PRMT1, PRMT6 ALDH1A1 3770/4885CHRNB2 2675/4885CHRNA5 550/4885
US-11208416-B2 Selective inhibitors of protein arginine methytransterase 5 (PRMT5) PRMT5, PRMT1, PRMT6 ALDH1A1 3770/4885CHRNB2 2675/4885CHRNA5 550/4885
US-20220160713-A1 SELECTIVE INHIBITOR OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) PRMT5, PRMT1, PRMT6 ALDH1A1 4156/4885CHRNB2 4559/4885CHRNA5 2175/4885
US-20200361946-A1 Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5) PRMT5, PRMT1, PRMT6 ALDH1A1 3770/4885CHRNB2 2675/4885CHRNA5 550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.